French firms need to scramble on reimbursement cuts
This article was originally published in Clinica
The French health ministry has published in the Journal officiel the list of cuts that the French healthcare product pricing committee, CEPS*, proposes making to the reimbursement prices of a series of medical supplies sold by device manufacturers to the private sector.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?